Evolution and Integration of Quality by Design and Process Analytical Technology

Quality by Design for Biopharmaceuticals: Principles and Case Studies

Volumn , Issue , 2008, Pages 255-286

  Low, Duncan ^a   Phillips, Joseph ^a  

^a AMGEN INC   (United States)

Author keywords

Chromatography critical purification tool in biotechnology; Evolution and integration of quality by design and process; QbD and PAT implementation

Indexed keywords

EID: 84889277364     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470466315.ch13     Document Type: Chapter

References (57)

1. Watts DC, Clark JE. Driving the future of pharmaceutical quality. J Process Anal Technol 2006;3(6):6-9.
2. PAT:AFramework for Innovative Pharmaceutical Development, Manufacturing and Quality Assurance, September. 2004. http://www.fda.gov.cder/guidance/6419fnl.pdf.
3. Pharmaceutical cGMPs for the 21st Century:ARisk-Based Approach, 2004. http://www.fda.gov/cder/gmp/gmp2004/CGMP%20report%20final04.pdf.
4. Challenge and Opportunity on the Critical Path to New Medical Products, March, 2004. http://www.fda.gov/oc/initiatives/criticalpath/whitepaper.html.
5. Pharmaceutical Development: Q8. http://www.ich.org/LOB/media/MEDIA1707.pdf.
6. Pharmaceutical Development: Annex to Q8. http://www.ich.org/LOB/media/MEDIA4349.pdf.
7. Pharmaceutical Risk Management: Q9. http://www.ich.org/LOB/media/MEDIA1957.pdf.
8. Pharmaceutical Quality System: Q10. http://www.ich.org/LOB/media/MEDIA3917.pdf.
9. EMEA PAT Home Page. http://www.emea.europa.eu/Inspections/PAThome.html.
10. Reflection Paper. Chemical, Pharmaceutical and Biological Information to be Included in Dossiers When Process Analytical Technology (PAT) is Employed, 2006. http://www.emea.europa.eu/Inspections/docs/PATGuidance.pdf.
11. ASTM E55 Committee Scope. http://www.astm.org/COMMIT/SCOPES/E55.htm.
12. Simmons S. The future direction of ASTM E55 Committee on manufacture of pharmaceutical products. Eur Pharm Rev 2007;12(6):71-76.
13. The National Technology Transfer and Advancement Act of 1995, 1995. http://www.tricare.osd.mil/jmis/download/PublicLaw104_113NationalTechnologyTransfer.pdf.
14. Winkle H. Address to ASTM E55 Committee, 2005. http://www.astm.org/COMMIT/E55_fda.pdf.
15. ChewR, PetkoD. Commissioningandqualification: a newASTMstandard:GMPregulations. Pharm Eng 2007;38-50.
16. Cohen N. Life sciences: an introduction to process analytical technology. Control Environ Mag 2004; available at http://www.cemag.us/articles.asp?pid=419.
17. Macher J, Nickerson J. Pharmaceutical IndustryWastes $50 Billion a Year Due to Inefficient Manufacturing, 2006. http://msb.georgetown.edu/newsroom/news/archive/2006/10/pharmaceutical_industry_wastes_/.
18. Cogdill R, Knight T, AndersonC, Drennan J. The financial returns on investments in process analytical technology and lean manufacturing: benchmarks and case study. J Pharm Innov 2007;2:38-50.
19. Maes I. Real-time product release based on fermentation monitoring (based on NIR) and feed-back control. IFPAC-2005 19th International Forum Process Analytical Technology, Arlington, VA; 2005.
20. Fahrner R, Blank G. Real-time monitoring of recombinant antibody breakthrough during protein A affinity chromatography. Biotechnol Appl Biochem 1999;29:109-112.
21. Cooley R. Michigan Pharmaceutical Education Seminar. 2003, http://www.fda.gov/cder/OPS/cooley/sld001.htm.
22. Lee A, Webber K, Ripple D, Tarlov M, Bruce E. Future technology needs for biomanufacturing: special session at IFPAC 2008 identifies goals and gaps IFPAC workshop. Biopharm Int 2008;21:12-14, also available at http://biopharminternational.findpharma.com/biopharm/News/Future-Technology-Needs-for-Biomanufacturing-Speci/ArticleStandard/Article/detail/502426?searchString1/4ifpac.
23. Lee A, Webber K, Ripple D, Tarlov M, Bruce E. IFPAC 2008: A Ten Year Vision for Biotechnology Manufacturing Session. 2008. http://web.mit.edu/cbi/docs/IFPAC08_Session%20Summary.pdf.
24. Rathore A, Johnson R, Yu O, Kirdar A, Annamalai A, Ahuja S, Ram K. Applications of multivariate data analysis in biotech processing. Biopharm Int 2007;20:130-134.
25. KirdarA, Conner J, Baclaski J, RathoreA. Applicationofmulti-variate analysis towardbiotech processes: case study of a cell-culture unit operation. Biotechnol Prog 2007;23:61-67.
26. Velayudhan A, Menon M. Modeling of purification operations in biotechnology: enabling process development, optimization and scale-up. Biotech Prog 2007;23:68-73.
27. Shukla A, Hubbard B, Tressel T, Guhan S, Low D. Downstream processing of monoclonal antibodies: application of platform approaches. J Chromatogr B 2007;848:28-39.
28. Pujar N, Low D, O'Leary R. Antibody purification: drivers of change in Gottschalk, U (ed) Process Scale Purification of Antibodies Wiley & Sons, New Jersey; 2009.
29. Standard Guide for Process Understanding Related to Pharmaceutical Manufacture and Control. http://www.astm.org/cgi-bin/SoftCart.exe/COMMIT/SUBCOMMIT/E5501.htm?L+memberstore+npxd3610+1206755405.
30. ASTM Standard E2474-06. Standard Practice for Pharmaceutical Process Design Utilizing Process Analytical Technology. ASTM International, West Conshohocken, PA; 2006.
31. Lanan M. Data management and advanced monitoring of biological processes. IFPAC Annual Meeting, Baltimore, MD; 2007.
32. Undey C. Data and systems management towards biopharmaceutical PAT-oriented scientific manufacturing. ISPE Conference on Manufacturing Excellence; 2008.
33. Moscariello J,Hendrickson R,Rydholm E,Hershberg R. Arapid technique to providere producible pressure-flow behaviour upon the scale-up of chromatography columns. 232nd American Chemical Society National Conference, San Francisco, BIOT Division. Abstract 48; 2006.
34. Wahome J, ZhouW, Kundu A. Impact of lot-to-lot variability of cation exchange chromatography resin on process performance. Biopharm Int 2008; 21:48-56, also available at http://biopharminternational.findpharma.com/biopharm/Downstream+Processing/Impact-of-Lot-to-Lot-Variability-of-Cation-Exchang/ArticleStandard/Article/detail/513395.
35. Aldington S, Bonnerjea J. Scale-up of monoclonal antibody purification processes. J Chromatogr B 2007;848:64-78.
36. Larson T, Davis J, Lam H, Cacia J. Use of process data to assess chromatographic performance in production-scale protein purification columns. Biotechnol Prog 2003;19:485-492.
37. Cooley R. Benefits of Process Analytical Technology (PAT) to optimization of Biotech Manufacturing IFPAC-19th International Forum Process Analytical Technology, Arlington, VA; 2005.
38. Bonam D. Implementing PAT in Biopharmaceutical Processes: Issues and Concerns IFPAC-2005 19th International Forum Process Analytical Technology, Arlington, VA; 2005.
39. Rathore A, Yu M, Yeboah S, Sharma A. Case study and application of process analytical technology (PAT) towards bioprocessing: use of on-line high performance liquid chromatography (HPLC) for making real-time pooling decisions for process chromatography. Biotechnol Bioeng 2008;100:306-316.
40. Tang X, Pikal M. Design of freeze drying processes for pharmaceuticals: practical advice. Pharm Res 2004;21(2):191-200.
41. Frinke G, Boeckem M, Steiner M. Advantages of PAT-Technologies for Cycle Development of Freeze Drying Processes, PDA Global PAT Conference, Bethesda, MD, May 22-23;2007.
42. Milton N, Pyne A, Mishra D, Yu L. The exploration and use of thermal analytical technologies during formulation process development of freeze dried products. Am Pharm Rev 2003;46-51.
43. Connelly J, Welch J. Monitor lyophilization with mass spectrometer gas analysis. J Parenter Sci Technol 1993;47(2):70-75.
44. RoyM, PikalM. Processcontrol in freeze drying: determination of theendpoint of sublimation drying by an electronic moisture sensor. J Parenter Sci Technol 1989;43(2);60-66.
45. Genin N, Rene F, Corrieu G. A method for on-line determination of residual water content and sublimation end-point during freeze-drying. Chem Eng Process 1996;35:255-263.
46. Tang X, Nail S, Pikal M. Evaluation of manometric temperature measurement, a process analytical technology tool for freeze-drying: part I, product temperature measurement. AAPS PharmSciTech 2006;7(1):E1-E9.
47. Tang X., Nail S, Pikal M. Evaluation of manometric temperature measurement, a process analytical technology tool for freeze-drying: part II, measurement of dry-layer resistance. AAPS PharmSciTech 2006;7(1):E1-E8.
48. Tang X, Nail S, Pikal M. Evaluation of manometric temperature measurement, a process analytical technology tool for freeze-drying: part III, heat and mass transfer measurement. AAPS PharmSciTech 2006;7(1):E1-E7.
49. Tang X, Nail S, Pikal M. Freeze-drying process design by manometric temperature measurement: design of a smart freeze-dryer. Pharm Res 2005;22:685-700.
50. Romero-Torres S, Wikström H, Grant E, Taylor L. Monitoring of mannitol phase behavior during freeze-drying using non-invasive Raman spectroscopy. PDA J Pharm Sci Technol 2007;61:131-145.
51. De Beer T, Allese M, Goethals F, Coppens A, Vander Heyden Y, Lopez De Diego H, Rantanen J, Verpoort F, Vervaet C, Remon J, Baeyens W. Implementation of a process analytical technology system in a freeze-drying process using Raman spectroscopy for in-line process monitoring. Anal Chem 2007;79:7992-8003.
52. Sukowski L, Ulmschneider M. In-line process analytical technology based on qualitative near-infrared spectroscopy modeling. Pharm Ind 2005;67:830-835.
53. MayeresseY, Veillon R, Sibille P, Nomine C. Freeze-drying process monitoring using a cold plasma ionization device. J Pharm Sci Technol 2007;61:160-174.
54. Gieseler H, Kessler W, Finson M, Davis S, Mulhall P, Bons V, Debo D, Pikal M. Evaluation of tunable diode laser absorption spectroscopy for in-process water vapor mass flux measurements during freeze drying. J Pharm Sci 2007;96:1776-1793.
55. Nail S, Searles J. Elements of quality by design in development and scale-up of freeze-dried parenterals. Biopharm Int 2008;21 VIS (January): 44-52.
56. Nasr M. Strategic Implementation of PAT: FDA Perspective IFPAC 2008 Workshop, Strategic Implementation of PAT, Baltimore, MD, January 27, 2008.
57. EMEA Report. Biologics Working Party (BWP), Process Analytical Technology (PAT) Group and Industry. Workshop on Process Analytic Technologies for Biologicals 15th March 2007. http://www.emea.europa.eu/pdfs/human/bwp/18537007en.pdf.